X
Please Wait
Applying Filters...
01 DR REDDYS LABS INC (3)
01 TABLET;ORAL (3)
01 RX (3)
01 IBUPROFEN (3)
01 No (3)
19
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is IBUPROFEN, with a corresponding application number 76112.
Regulatory Information RX
With a dosage strength 600MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2001-10-31
Therapeutic Equivalence (TE) Code AB
18
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is IBUPROFEN, with a corresponding application number 76112.
Regulatory Information RX
With a dosage strength 800MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2001-10-31
Therapeutic Equivalence (TE) Code AB
17
Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is IBUPROFEN, with a corresponding application number 76112.
Regulatory Information RX
With a dosage strength 400MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2001-10-31
Therapeutic Equivalence (TE) Code AB
Market Place
KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
